000 01026 a2200265 4500
005 20250515181657.0
264 0 _c20091023
008 200910s 0 0 eng d
022 _a1759-5037
024 7 _a10.1038/nrendo.2009.151
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJacobson, Terry A
245 0 0 _aMyopathy with statin-fibrate combination therapy: clinical considerations.
_h[electronic resource]
260 _bNature reviews. Endocrinology
_cSep 2009
300 _a507-18 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aClofibric Acid
_xadverse effects
650 0 4 _aFenofibrate
_xadverse effects
650 0 4 _aHumans
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
_xtherapeutic use
650 0 4 _aHyperlipidemias
_xdrug therapy
650 0 4 _aHypolipidemic Agents
_xadverse effects
773 0 _tNature reviews. Endocrinology
_gvol. 5
_gno. 9
_gp. 507-18
856 4 0 _uhttps://doi.org/10.1038/nrendo.2009.151
_zAvailable from publisher's website
999 _c19044427
_d19044427